Cannabis

There are over 100+ unexplored cannabinoids in medicine

Latest News

Ronstik/AdobeStock
The Week in Review: February 24-28

February 28th 2025

Here are highlights from this week in Psychiatric Times, including a special report on psychiatric symptoms of celiac disease and the potential dangers of cannabis use in older patients.

cannabis
Cannabis Use in Senior Patients

February 25th 2025

cannabis
Is the Case Settled? Cannabis and Criminal Responsibility

January 13th 2025

catatonia
From Stupor to Success: Managing Catatonia in Rural South Africa, A Case Report

December 9th 2024

cannabis
Psychiatry’s Risky Gamble on Recreational Drugs: The Royal Road to the Unconscious or Down a Pharmacologic Garden Path

September 12th 2024

Video Interviews
Podcasts
Latest CME Events & Activities

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

View More

More News

© 2025 MJH Life Sciences

All rights reserved.